首页> 外国专利> Group-sparse nonnegative supervised canonical correlation analysis (GNCCA)

Group-sparse nonnegative supervised canonical correlation analysis (GNCCA)

机译:群体稀疏非负监督典型相关分析(GNCCA)

摘要

Methods, apparatus, application specific integrated circuits (ASIC)s and other embodiments associated with analyzing a cancerous prostate using group-sparse non-negative canonical correlation analysis (GNCCA) with a variable importance in the projections (VIP) score are described. One example apparatus includes a set of logics that acquires a set of features from a plurality of feature views of a region of tissue demonstrating cancerous pathology, produces a ranked set of discriminative features using GNCCA with the VIP score, optimizes computation of the GNCCA using a vector-block coordinate descent (BCD) approach, and provides a prostate cancer (CaP) grade or a biochemical recurrence (BcR) score based on the set of discriminative features. Embodiments of example apparatus may generate and display the CaP grade, BcR score, or set of discriminative features.
机译:描述了与使用在预测(VIP)得分中具有可变重要性的组稀疏非负规范相关分析(GNCCA)来分析癌性前列腺相关的方法,设备,专用集成电路(ASIC)和其他实施例。一个示例装置包括一组逻辑,该一组逻辑从组织区域的多个特征视图中获取一组特征,以证明癌性病理,使用具有VIP评分的GNCCA产生一组排序的判别特征,并使用ANC来优化GNCCA的计算。向量块协调下降(BCD)方法,并基于判别特征集提供前列腺癌(CaP)等级或生化复发(BcR)评分。示例设备的实施例可以生成并显示CaP等级,BcR分数或判别特征集。

著录项

  • 公开/公告号US9984212B2

    专利类型

  • 公开/公告日2018-05-29

    原文格式PDF

  • 申请/专利权人 CASE WESTERN RESERVE UNIVERSITY;

    申请/专利号US201514612317

  • 发明设计人 HAIBO WANG;ANANT MADABHUSHI;

    申请日2015-02-03

  • 分类号G01N33/48;G01N33/50;G06F19/00;G06T7/00;A61B5/00;G06K9/62;G06K9/00;A61B5/055;G01R33/56;

  • 国家 US

  • 入库时间 2022-08-21 12:56:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号